Nexgel (NXGLW) Cash from Financing Activities (2018 - 2025)

Nexgel (NXGLW) reported Cash from Financing Activities of -$1.0 million for Q4 2025, down 162.34% on a YoY basis from $1.7 million in Q4 2024, and down 154.05% quarter-over-quarter from $1.9 million in Q3 2025.

Nexgel (NXGLW) Cash from Financing Activities (2018 - 2025) Analysis & Trends

Nexgel has reported Cash from Financing Activities for 8 years, with the latest figure at -$1.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 162.34% year-over-year to -$1.0 million; the trailing twelve-month figure through Dec 2025 stood at $630000.0 (down 83.2% YoY), and the FY2025 full-year result was $630000.0, down 83.2% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at -$1.0 million, down from $1.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $13.2 million in Q4 2021, with the low at -$2.0 million in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $968666.7 across 5 years, with a median of $43500.0 in 2023.
  • The largest YoY upside for Cash from Financing Activities was 46550.0% in 2024 against a maximum downside of 6300.0% in 2024.
  • Nexgel's Cash from Financing Activities stood at $13.2 million in 2021, then tumbled by 101.14% to -$150000.0 in 2022, then jumped by 296.0% to $294000.0 in 2023, then soared by 468.03% to $1.7 million in 2024, then tumbled by 162.34% to -$1.0 million in 2025.
  • The last three Cash from Financing Activities figures came in at -$1.0 million (Q4 2025), $1.9 million (Q3 2025), and -$40000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -1.35 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -414.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -13.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -255.24 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -308.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -50.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -75.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -48.13 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -11.00 Mn
10 Nexgel - - 819,000.00 -1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.04 Mn
Dec 31, 2025 -1.04 Mn
Sep 30, 2025 1.93 Mn
Sep 30, 2025 1.93 Mn
Jun 30, 2025 -40,000.00
Jun 30, 2025 -40,000.00
Mar 31, 2025 -215,000.00
Mar 31, 2025 -215,000.00
Dec 31, 2024 1.67 Mn
Dec 31, 2024 1.67 Mn
Sep 30, 2024 1.21 Mn
Sep 30, 2024 1.21 Mn
Jun 30, 2024 -64,000.00
Jun 30, 2024 -64,000.00
Mar 31, 2024 929,000.00
Mar 31, 2024 929,000.00
Dec 31, 2023 294,000.00
Dec 31, 2023 294,000.00
Sep 30, 2023 88,000.00
Sep 30, 2023 88,000.00